» Articles » PMID: 38725974

Alternative Treatment of Polycystic Ovary Syndrome: Pre-clinical and Clinical Basis for Using Plant-based Drugs

Overview
Specialty Endocrinology
Date 2024 May 10
PMID 38725974
Authors
Affiliations
Soon will be listed here.
Abstract

The most common cause of infertility and metabolic problems among women of reproductive age is polycystic ovary syndrome (PCOS), a multifaceted disorder. It is an endocrine disorder that occurs in approximately one in seven women. Among these PCOS patients, two thirds will not ovulate on a regular basis and seek treatment for ovulation induction. The symptoms vary in their severity, namely ovulation disorders, excessive androgen levels, or polycystic ovarian morphology. All these symptoms require a therapeutic approach. Many drugs are used to eradicate PCOS symptoms, like metformin, clomiphene citrate, spironolactone, and pioglitazone. Long-term treatment is required to achieve the desired outcome, which is often accompanied by significant adverse reactions. Some herbs and phytochemicals are equally effective for treating PCOS and produce minimal side effects. Recently, herbal products are gaining popularity due to their wide biological activities, safety, availability, and efficacy. The present review covers aetiology, current treatment, pathophysiology, and detailed pre-clinical and clinical studies on plants and phytochemicals that are proven to be useful for the treatment of symptoms associated with PCOS.

Citing Articles

Natural compounds in the management of polycystic ovary syndrome: a comprehensive review of hormonal regulation and therapeutic potential.

Yuan J, Li Z, Yu Y, Wang X, Zhao Y Front Nutr. 2025; 12:1520695.

PMID: 40008316 PMC: 11850276. DOI: 10.3389/fnut.2025.1520695.


Comparison of GLP-1 Receptor Agonists Combined with Metformin Versus Metformin Alone in the Management of PCOS: A Comprehensive Meta-Analysis.

Zhao Y, Jiang L, Li N, Cao J, Pi J Reprod Sci. 2025; .

PMID: 39881036 DOI: 10.1007/s43032-025-01788-9.


Higher oxidative balance score is associated with lower female infertility: a cross-sectional study.

Lei X, Liu X, Yu C, Xia L, Zhou L, Yao C Front Nutr. 2024; 11:1484756.

PMID: 39703331 PMC: 11658776. DOI: 10.3389/fnut.2024.1484756.


Apigenin as a Promising Agent for Enhancing Female Reproductive Function and Treating Associated Disorders.

Sirotkin A, Harrath A Biomedicines. 2024; 12(10).

PMID: 39457717 PMC: 11504338. DOI: 10.3390/biomedicines12102405.


Phytochemicals-based investigation of pharmacological potential against letrozole-induced polycystic ovarian syndrome in female adult rats: , and mechanistic approach.

Zhang J, Arshad K, Siddique R, Xu H, Alshammari A, Albekairi N Heliyon. 2024; 10(14):e34298.

PMID: 39108850 PMC: 11301150. DOI: 10.1016/j.heliyon.2024.e34298.

References
1.
Zhang S, Zhou J, Gober H, Leung W, Wang L . Effect and mechanism of berberine against polycystic ovary syndrome. Biomed Pharmacother. 2021; 138:111468. DOI: 10.1016/j.biopha.2021.111468. View

2.
Palomba S, Daolio J, La Sala G . Oocyte Competence in Women with Polycystic Ovary Syndrome. Trends Endocrinol Metab. 2016; 28(3):186-198. DOI: 10.1016/j.tem.2016.11.008. View

3.
Palomba S, Piltonen T, Giudice L . Endometrial function in women with polycystic ovary syndrome: a comprehensive review. Hum Reprod Update. 2020; 27(3):584-618. DOI: 10.1093/humupd/dmaa051. View

4.
Wang Z, Zhai D, Zhang D, Bai L, Yao R, Yu J . Quercetin Decreases Insulin Resistance in a Polycystic Ovary Syndrome Rat Model by Improving Inflammatory Microenvironment. Reprod Sci. 2016; 24(5):682-690. DOI: 10.1177/1933719116667218. View

5.
Havsteen B . Flavonoids, a class of natural products of high pharmacological potency. Biochem Pharmacol. 1983; 32(7):1141-8. DOI: 10.1016/0006-2952(83)90262-9. View